New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 23, 2014
10:00 EDTPTCTPTC Therapeutics rises 60.2%
PTC Therapeutics is up 60.2%, or $9.23, to $24.55
News For PTCT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 16, 2015
10:00 EDTPTCTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:58 EDTPTCTPTC Therapeutics upgraded to Outperform at Cowen
As previously reported, Cowen upgraded PTC Therapeutics to Outperform from Market Perform ahead of its upcoming ACT-DMD data in the fourth quarter. The firm expects positive Phase 3 data after Phase 2 data established proof of concept. Cowen raised its price target to $120 from $70 on PTC Therapeutics to reflect the chance of success of Translarna in DMD.
07:55 EDTPTCTPTC Therapeutics upgraded to Outperform from Market Perform at Cowen
Subscribe for More Information
April 9, 2015
10:48 EDTPTCTDeutsche compares PTC Therapeutics to Vertex, boosts target by $40
Subscribe for More Information
07:27 EDTPTCTPTC Therapeutics price target raised to $115 from $75 at Deutsche Bank
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use